Answers are grounded in this paper and cite their sources.
Metabolic imaging with PET provides valuable insights into myocardial viability, ischemia, hibernation, and stunning in patients with coronary artery disease, aiding clinical management.
Positron emission tomography offers the possibility of evaluating and quantifying regional myocardial blood flow and metabolism. Used in patients with coronary artery disease, positron emission tomography has demonstrated sustained metabolic activity in regions with reduced blood flow and impaired contractile function, and it thereby enables differentiation between viable myocardium and myocardium that has succumbed to necrosis and scar formation. Viable myocardial regions identified by metabolic rather than functional or blood-flow criteria are frequently observed in patients after an acute coronary event and in patients with stable coronary artery disease. Positron emission tomography reflects either acute myocardial ischemia, "hibernation," as well as "myocardial stunning." Findings from metabolic imaging have proved useful in characterizing more accurately coronary artery disease and its functional consequences. These findings have been found equally useful for clinical management.
No takes yet. Share an insight, caveat, or question.
Schelbert et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: